I don't imagine it will cost us pro-rata of current MC ($300 mill) for the 15% - I'm expecting far less.
Given we already have full equity for 4.5mtpa and recent announcements regarding CATH extension, I don't see any other need for a cap raise - but we shall wait and see
- Forums
- ASX - By Stock
- AVZ
- Ann: Trading Halt
Ann: Trading Halt, page-76
-
-
- There are more pages in this discussion • 337 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVZ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online